Technology
Health
Pharmaceutical

Allergan

$162.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-0.32%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell Allergan and other stocks, options, ETFs, and crypto commission-free!

About AGN

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. Read More The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Employees
16,900
Headquarters
Dublin, Dublin
Founded
1984
Market Cap
53.48B
Price-Earnings Ratio
—
Dividend Yield
2.15
Average Volume
4.81M
High Today
$163.52
Low Today
$162.51
Open Price
$162.98
Volume
2.36M
52 Week High
$197.00
52 Week Low
$114.27

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Europe (Non-UK)
Europe

AGN News

Barron'sJul 16

Allergan Stock Won’t Rise Much More, Analyst Says, in Looking at Deal With AbbVie

1,290
Wall Street JournalJul 6

Plan on More Pharma Megamergers

341
BloombergJun 26

Elliott Management Advocated for an Allergan Split Prior to Sale

462

AGN Earnings

$3.36
$3.86
$4.36
$4.86
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, Pre-Market

Popular Stocks

More AGN News

Yahoo FinanceJun 26

AbbVie's $63 billion Allergan deal shakes up big pharma

401
Barron'sJun 26

AbbVie Stock Is Rising as Some See ‘Considerable’ Opportunity in Selloff

1,253
MarketWatchJun 26

Allergan acquisition is ‘a major bailout’ for shareholders, according to analysts

80
CNBCJun 26

AbbVie deal may conclude a tumultuous 4 years for Botox-maker Allergan

321
Wall Street JournalJun 25

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion

34
Wall Street JournalJun 25

Tax Reform’s Remedy for Outsourcing

419
FortuneJun 25

What the $63 Billion AbbVie Allergan Deal Says About the Drug Industry: Brainstorm Health

1,669
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.